FerlayJ SI, ErvikM, DikshitR, et al.GLOBOCAN 2012 v 1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. http://globocan.iarc.fr.
2.
PatelAR, PrasadSM, ShihYC, EggenerSE. The association of the human development index with global kidney cancer incidence and mortality. J Urol, 2012; 187:1978–1983.
3.
ZnaorA, Lortet-TieulentJ, LaversanneM, et al.International variations and trends in renal cell carcinoma incidence and mortality. Eur Urol, 2015; 67:519–530.
4.
LeppertJT, HanleyJ, WagnerTH, et al.Utilization of renal mass biopsy in patients with renal cell carcinoma. Urology, 2014; 83:774–779.
5.
GhaniKR, SukumarS, SammonJD, et al.Practice patterns and outcomes of open and minimally invasive partial nephrectomy since the introduction of robotic partial nephrectomy: Results from the nationwide inpatient sample. J Urol, 2014; 191:907–912.
6.
LagunaMP, AlgabaF, CadedduJ, et al.Current patterns of presentation and treatment of renal masses: A clinical research office of the endourological society prospective study. J Endourol, 2014; 28:861–870.
7.
CormioL, de la RosetteJ. The upper tract-transitional-cell carcinoma global study: A prospective observational study exploring indications, treatment modalities, and outcomes worldwide. J Endourol, 2014; 28:500–501.
